Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126

Peter S Hamblin^{1

2}, Rosemary Wong^{3

4}, Elif I Ekinci^{5

6}, Shoshana Sztal-Mazer^{7

8

9}, Shananthan Balachandran³, Aviva Frydman¹, Timothy P Hanrahan¹⁰, Raymond Hu^{6

11}, Shara N Ket¹², Alan Moss^{2

13}, Mark Ng^{4

14}, Sashikala Ragunathan^{15

16}, Leon A Bach^{7

17}

Affiliations

¹ 1Department of Endocrinology & Diabetes, Western Health, Melbourne, Australia.
² 2Department of Medicine, Western Health, The University of Melbourne, Australia.
³ 3Department of Endocrinology and Diabetes, Eastern Health, Melbourne, Australia.
⁴ 4Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
⁵ 5Department of Endocrinology, Austin Health, Melbourne, Australia.
⁶ 6Melbourne Medical School, The University of Melbourne, Australia.
⁷ 7Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Australia.
⁸ 8School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.
⁹ 9Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.
¹⁰ 10Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Australia.
¹¹ 11Department of Anaesthesia, Austin Health, Melbourne, Australia.
¹² 12Department of Gastroenterology, Alfred Health, Melbourne, Australia.
¹³ 13Department of Endoscopic Services, Western Health, Melbourne, Australia.
¹⁴ 14Department of Anaesthesia, Pain and Perioperative Medicine, Eastern Health, Melbourne, Australia.
¹⁵ 15Department of Gastroenterology, Austin Health, Melbourne, Australia.
¹⁶ 16Gastroenterological Nurses College of Australia, Melbourne, Australia.
¹⁷ 17Department of Medicine, Central Clinical School Monash University, Victoria, Australia.

Comment

Peter S Hamblin et al. Diabetes Care. 2022.

. 2022 Jan 1;45(1):e17-e18.

doi: 10.2337/dci21-0048.

¹ 1Department of Endocrinology & Diabetes, Western Health, Melbourne, Australia.
² 2Department of Medicine, Western Health, The University of Melbourne, Australia.
³ 3Department of Endocrinology and Diabetes, Eastern Health, Melbourne, Australia.
⁴ 4Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
⁵ 5Department of Endocrinology, Austin Health, Melbourne, Australia.
⁶ 6Melbourne Medical School, The University of Melbourne, Australia.
⁷ 7Department of Endocrinology and Diabetes, Alfred Health, Melbourne, Australia.
⁸ 8School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.
⁹ 9Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.
¹⁰ 10Department of Gastroenterology and Liver Transplant Unit, Austin Health, Melbourne, Australia.
¹¹ 11Department of Anaesthesia, Austin Health, Melbourne, Australia.
¹² 12Department of Gastroenterology, Alfred Health, Melbourne, Australia.
¹³ 13Department of Endoscopic Services, Western Health, Melbourne, Australia.
¹⁴ 14Department of Anaesthesia, Pain and Perioperative Medicine, Eastern Health, Melbourne, Australia.
¹⁵ 15Department of Gastroenterology, Austin Health, Melbourne, Australia.
¹⁶ 16Gastroenterological Nurses College of Australia, Melbourne, Australia.
¹⁷ 17Department of Medicine, Central Clinical School Monash University, Victoria, Australia.

No abstract available

Comment on

Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes.
Hamblin PS, Wong R, Ekinci EI, Sztal-Mazer S, Balachandran S, Frydman A, Hanrahan TP, Hu R, Ket SN, Moss A, Ng M, Ragunathan S, Bach LA. Hamblin PS, et al. Diabetes Care. 2021 Jun;44(6):e124-e126. doi: 10.2337/dc21-0256. Epub 2021 Apr 25. Diabetes Care. 2021. PMID: 33896795 Free PMC article. No abstract available.
Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126.
Thiruvenkatarajan V, Meyer EJ, Jesudason D. Thiruvenkatarajan V, et al. Diabetes Care. 2022 Jan 1;45(1):e15-e16. doi: 10.2337/dc21-1413. Diabetes Care. 2022. PMID: 34986260 No abstract available.